Tretinoin Online


Buy Renova, Retin-A (Tretinoin) anti-acne, anti-age, skin care products online
Cheap qualitative Tretinoin cream and gel 0.025%, 0.05%, 0.1% 20 g in tubes



HOW AND WHERE TO BUY RETIN-A, RENOVA (TRETINOIN) 0.025%, 0.05%, 0.1% 20 G GEL AND CREAM ONLINE:


PHARMA SHOP

Lowest prices
Good quality
from $8.90 per tube 20 g
Cream and Gel
10% discount coupon: hf-5478



DISCOUNT MEDS

Low prices
High quality
from $9.30 per tube 20 g
Cream
5% discount coupon: dmeds5



DRUGS FOR HEALTH

Average prices
Best quality
from $9.39 per tube 20 g
Gel and Cream
5% discount coupon: A1XKPKC


For more offers please visit
PHARMA DOCTOR: TRETINOIN



RETIN-A (TRETINOIN) CREAM, GEL, LIQUID: NONCLINICAL TOXICOLOGY

Carcinogenesis, Mutagenesis, Impairment to Fertility

In a 91-week dermal study in which CD-1 mice were administered 0.017% and 0.035% formulations of tretinoin, cutaneous squamous cell carcinomas and papillomas in the treatment area were observed in some female mice. A dose-related incidence of liver tumors in male mice was observed at those same doses. The maximum systemic doses associated with the administered 0.017% and 0.035% formulations are 0.5 and 1.0 mg/kg/day, respectively. These doses are two and four times the maximum human systemic dose, when adjusted for total body surface area. The biological significance of these findings is not clear because they occurred at doses that exceeded the dermal maximally tolerated dose (MTD) of tretinoin and because they were within the background natural occurrence rate for these tumors in this strain of mice. There was no evidence of carcinogenic potential when 0.025 mg/kg/day of tretinoin was administered topically to mice (0.1 times the maximum human systemic dose, adjusted for total body surface area). For purposes of comparisons of the animal exposure to systemic human exposure, the maximum human systemic dose is defined as 1 gram of 0.1% Retin-A (Tretinoin) applied daily to a 50 kg person (0.02 mg tretinoin/kg body weight).

Studies in hairless albino mice suggest that concurrent exposure to tretinoin may enhance the tumorigenic potential of carcinogenic doses of UVB and UVA light form a solar simulator. This effect has been confirmed in a later study in pigmented mice, and dark pigmentation did not overcome the enhancement of photocarcinogenesis by 0.05% tretinoin. Although the significance of these studies to humans is not clear, patients should minimize exposure to sunlight or artificial ultraviolet irradiation sources.

The mutagenic potential of tretinoin was evaluated in the Ames assay and in the in vivo mouse micronucleus assay, both of which were negative.

In dermal Segment I fertility studies of another tretinoin formulation in rats, slight (not statistically significant) decreases in sperm count and motility were seen at 0.5 mg/kg/day (4 times the maximum human systemic dose adjusted for total body surface area), and slight (not statistically significant) increases in the number and percent of nonviable embryos in females treated with 0.25 mg/kg/day (2 times the maximum human systemic dose adjusted for total body surface area) and above were observed. A dermal Segment III study with Tretinoin (Retin-A) has not been performed in any species. In oral Segment I and Segment III studies in rats with tretinoin, decreased survival of neonates and growth retardation were observed at doses in excess of 2 mg/kg/day (16 times the human topical does adjusted for total body surface area).



Retin-A (Tretinoin) related pharmaceutical drugs and medications

Trade name of the drug Pharmaceutical forms and doses Companies
Accutane nonclinical toxicology
  • Capsules; Oral; Isotretinoin 20 mg
  • Roche
  • AIMS Traders


  • Recent posts:

  • Buy Retin-A (Tretinoin) Online
  • Retin-A prescribing information

    Copyright © Tretinoinbuyonline.com